Sargent Investment Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-50,000
Closed -$27.5K 207
2023
Q2
$27.5K Buy
50,000
+15,000
+43% +$289K 0.01% 199
2023
Q1
$56K Buy
+35,000
New +$610K 0.01% 192
2022
Q3
Sell
-87,500
Closed -$134K 193
2022
Q2
$134K Buy
87,500
+37,500
+75% +$773K 0.04% 174
2022
Q1
$190K Buy
+50,000
New +$977K 0.05% 177
2020
Q4
Sell
-20,000
Closed -$19K 190
2020
Q3
$19K Buy
+20,000
New +$467K 0.01% 163

Other funds holding EXEL

Sargent Investment Group's EXEL Position: Q1 2026 in Review

Sargent Investment Group reduced its Exelixis (EXEL) stake by 6.8% in Q1 2026, selling an estimated $561K and leaving 179,025 shares worth $7.68M. The position accounts for 1.01% of the portfolio, ranked #25.

Sargent Investment Group first reported a position in EXEL in Q4 2018 and has held it in 30 quarters since. The position peaked at $12.8M in Q3 2020. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Sargent Investment Group held 179,025 shares of Exelixis worth $7.68M as of Q1 2026.
  • Sargent Investment Group sold 13,040 Exelixis shares in Q1 2026, an estimated $561K.
  • Exelixis made up 1.01% of Sargent Investment Group's portfolio in Q1 2026, its #25 holding.
  • Sargent Investment Group first reported a position in Exelixis in Q4 2018 and has held it in 30 quarters since.
  • Sargent Investment Group's Exelixis position peaked at $12.8M in Q3 2020.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.